Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001654954-20-008864
Filing Date
2020-08-11
Accepted
2020-08-11 16:05:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A sc13da_am4.htm SC 13D/A 97865
  Complete submission text file 0001654954-20-008864.txt   99254
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89966 | Film No.: 201092430
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JDJ FAMILY OFFICE SERVICES P.O. BOX 962049 BOSTON MA 02196
Business Address
Ross Edmund Burke Jr. (Filed by) CIK: 0001682557 (see all company filings)

Type: SC 13D/A